From April 1, 2023 to June 30, 2023, the company has repurchased 7,283,466 shares, representing 12.03% for $80.48 million. With this, the company has completed the repurchase of 25,222,581 shares, representing 37.22% for $263.74 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.47 USD | -0.21% | +1.07% | -15.75% |
04-12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
04-12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.75% | 460M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.15% | 239B | |
+8.00% | 204B | |
-7.61% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.